PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS
Crwe World,
Highlights: Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® Preliminary efficacy…
Highlights: Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® Preliminary efficacy…
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS PR Newswire PERTH, Australia, Feb.
Highlights: Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® Preliminary efficacy…
Highlights: Monepantel displays a superior safety, tolerability to the leading FDA approved drug Relyvrio® Preliminary efficacy…